Ultima-Ipamorelin, 2 mg

Ultima-Ipamorelin 2 mg contains ipamorelin, a selective growth hormone secretagogue that stimulates the release of growth hormone (GH). It is particularly associated with recovery, lean-muscle development, body composition, sleep support, and growth-hormone signaling, making it a popular peptide for fitness and performance-focused applications.

How it works

Ipamorelin works primarily through the growth hormone secretagogue receptor (GHS-R), stimulating the pituitary gland to release growth hormone.

Its selective activity makes ipamorelin particularly interesting for protocols focused on GH release and recovery. Increased GH activity can influence the GH–IGF-1 axis, supporting processes related to protein synthesis, tissue recovery, fat metabolism, and body composition.

Proper Use and Dosage

The listed presentation contains 2 mg (2,000 mcg) of ipamorelin.

Commonly referenced peptide protocols use approximately 100–300 mcg per administration, depending on the intended application.

For a 2 mg presentation:

• 50 mcg = 40 administrations
• 100 mcg = 20 administrations
• 150 mcg = approximately 13 administrations
• 200 mcg = 10 administrations
• 250 mcg = 8 administrations
• 300 mcg = approximately 6–7 administrations
• 500 mcg = 4 administrations
• 1 mg = 2 administrations
• 2 mg = 1 full vial

For fitness-focused applications, ipamorelin is commonly incorporated into protocols centered around growth-hormone support, recovery, sleep, lean-mass development, and body composition.

Benefits

Ultima-Ipamorelin is particularly suited to applications involving growth-hormone stimulation, recovery, muscle development, sleep, and physique enhancement.

Key benefits and areas of interest include:

• Stimulates endogenous growth hormone release
• Supports GH–IGF-1 pathway activity
• Supports lean-muscle development
• Promotes recovery after demanding training
• Supports tissue-repair pathways
• May complement fat-loss and body-composition goals
• Supports sleep-related growth-hormone activity
• Provides selective growth-hormone secretagogue activity
• Suitable for recovery-focused peptide protocols
• Convenient 2 mg presentation

Its selective GH-secretagogue profile makes ipamorelin particularly attractive for individuals looking for growth-hormone support without directly administering HGH.

Side Effects

Possible effects may include injection-site irritation, headache, dizziness, nausea, fatigue, increased appetite, water retention, and temporary changes in blood glucose. Increased GH activity may also contribute to joint discomfort, swelling, or tingling sensations in some individuals.